{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:43:14Z","timestamp":1770918194621,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.dld.2022.12.012","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T08:27:00Z","timestamp":1673944020000},"page":"305-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The natural history of COVID-19 in vaccinated inflammatory bowel disease patients"],"prefix":"10.1016","volume":"55","author":[{"given":"N.","family":"Viazis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Drygiannakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Karmiris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Theodoropoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Zampeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tzouvala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bamias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Liatsos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Theocharis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vrakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tsironi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Mathou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mantaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Christidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Koustenis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ch.","family":"Veretanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Papathanasiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Zacharopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Tribonias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Kitsou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kartsoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Theodoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Michopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Thomopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.E.","family":"Koutroubakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.J.","family":"Mantzaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2022.12.012_bib0001","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.dld.2022.12.012_bib0002","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/22221751.2021.1898291","article-title":"Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic","volume":"10","author":"To","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.dld.2022.12.012_bib0003","unstructured":"European Centre for Disease Prevention and Control. Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU\/EEA, 2021."},{"key":"10.1016\/j.dld.2022.12.012_bib0004","article-title":"Treatment of inflammatory bowel disease: a comprehensive review","volume":"8","author":"Cai","year":"2021","journal-title":"J.Front Med"},{"key":"10.1016\/j.dld.2022.12.012_bib0005","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1136\/gutjnl-2021-324789","article-title":"Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD","volume":"70","author":"Kennedy","year":"2021","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.dld.2022.12.012_bib0006","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/gutjnl-2020-324000","article-title":"CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting","volume":"70","author":"Siegel","year":"2021","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.dld.2022.12.012_bib0007","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41575-021-00420-w","article-title":"SARS- CoV-2 vaccination in IBD: more pros than cons","volume":"18","author":"D'Amico","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2022.12.012_bib0008","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/jcm11030641","article-title":"On behalf of the hellenic group for the study of IBD. Real-world use and adverse events of SARS-CoV-2 vaccination in Greek patients with inflammatory bowel disease","volume":"11","author":"Orfanoudaki","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.dld.2022.12.012_bib0009","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S2468-1253(22)00005-X","article-title":"COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study","volume":"7","author":"Alexander","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.dld.2022.12.012_bib0010","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.cgh.2022.02.030","article-title":"Effectiveness and durability of COVID-19 vaccination in 9477 patients with IBD: a systematic review and meta-analysis","volume":"20","author":"Jena","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.12.012_bib0011","doi-asserted-by":"crossref","first-page":"e810","DOI":"10.1097\/MEG.0000000000002267","article-title":"The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD","volume":"33","author":"Bamias","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.12.012_bib0012","first-page":"jjac091","article-title":"The impact of COVID-19 in patients with IBD in a prospective European cohort study","author":"Amiot","year":"2022","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.dld.2022.12.012_bib0013","unstructured":"SECURE-IBD Database. Current summary data. https:\/\/covidibd.org\/current-data\/. [date last updated 25 January 2022]"},{"key":"10.1016\/j.dld.2022.12.012_bib0014","unstructured":"Daily Reports COVID-19 - National Public Health Organisation. https:\/\/eody.gov.gr\/epidimiologika-statistika-dedomena\/ektheseis-covid-19 [date last updated 10 July2022]"},{"key":"10.1016\/j.dld.2022.12.012_bib0015","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/gutjnl-2020-321244","article-title":"British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic","volume":"69","author":"Kennedy","year":"2020","journal-title":"Gut"},{"issue":"Suppl_3","key":"10.1016\/j.dld.2022.12.012_bib0016","doi-asserted-by":"crossref","first-page":"S798","DOI":"10.1093\/ecco-jcc\/jjaa160","article-title":"Inflammatory bowel disease management during the covid-19 outbreak: the ten do's and don'ts from the ECCO-COVID task force","volume":"14","author":"Magro","year":"2020","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.dld.2022.12.012_bib0017","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/j.gastro.2020.04.012","article-title":"AGA clinical practice update on management of inflammatory bowel disease during the COVID-19 pandemic: expert commentary","volume":"159","author":"Rubin","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.12.012_bib0018","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/ijcp.12382","article-title":"Anti-TNF-alpha therapy for patients with sepsis: a systematic meta-analysis","volume":"68","author":"Lv","year":"2014","journal-title":"Int J Clin Pract"},{"issue":"8","key":"10.1016\/j.dld.2022.12.012_bib0019","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/ibd\/izab236","article-title":"COVID-19 and outcomes in patients with inflammatory bowel disease: systematic review and meta-analysis","volume":"28","author":"Tripathi","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2022.12.012_bib0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ecco-jcc\/jjz110","article-title":"IM-UNITI: three-year efficacy, safety, and immunogenicity of ustekinumab treatment of Crohn's disease","volume":"14","author":"Hanauer","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.dld.2022.12.012_bib0021","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.gastro.2021.09.011","volume":"162","author":"Ungaro","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.12.012_bib0022","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2567.2007.02671.x","article-title":"Differential expression of adhesion molecules and chemokines between nasal and small intestinal mucosae: implications for T- and sIgA+ B-lymphocyte recruitment","volume":"122","author":"Bourges","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.dld.2022.12.012_bib0023","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/gutjnl-2015-311079","article-title":"The safety of vedolizumab for ulcerative colitis and Crohn's disease","volume":"66","author":"Rutgeerts","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.dld.2022.12.012_bib0024","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.14075","article-title":"Systematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease","volume":"46","author":"Bye","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.dld.2022.12.012_bib0025","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/ecco-jcc\/jjab071","article-title":"The impact of vedolizumab on COVID-19 outcomes among adult IBD patients in the secure-IBD registry","volume":"15","author":"Agrawal","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2022.12.012_bib0026","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s10620-019-05492-y","article-title":"Real-world experience with tofacitinib in IBD at a Tertiary Center","volume":"64","author":"Weisshof","year":"2019","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.dld.2022.12.012_bib0027","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/apt.15779","article-title":"Review article: prevention, diagnosis and management of COVID-19 in the IBD patient","volume":"52","author":"Al-Ani","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"11\u201312","key":"10.1016\/j.dld.2022.12.012_bib0028","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/apt.16663","article-title":"Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study","volume":"54","author":"Bezzio","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"10328","key":"10.1016\/j.dld.2022.12.012_bib0029","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2022.12.012_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2022.100180","article-title":"Breakthrough infections after COVID-19 vaccination. Insights, perspectives and challenges","volume":"14","author":"Amanatidou","year":"2022","journal-title":"Metabol Open"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822008623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822008623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:22:32Z","timestamp":1761625352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865822008623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1590865822008623"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2022.12.012","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The natural history of COVID-19 in vaccinated inflammatory bowel disease patients","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2022.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}